© 2022 MJH Life Sciences and Cancer Network. All rights reserved.
© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
A panel of oncologists discuss recent updates in the management of patients with myelofibrosis and share insight into their strategies for two case scenarios.
June 27th 2022
Srdan Verstovsek, MD, PhD, provides an overview of how myelofibrosis is diagnosed and what criteria are used for risk stratification.
Aaron Gerds, MD, explains the various types of myelofibrosis and the underlying pathophysiologies.